Dyslipidemia in patients with chronic and end-stage kidney disease

Jad Omran, Ashraf Al-Dadah, Kevin C. Dellsperger

Research output: Contribution to journalReview article

17 Scopus citations

Abstract

In this review, we discuss the physiology, diagnosis and treatment of dyslipidemia in patients with chronic and end-stage renal disease. The recent important clinical trials in patients with chronic kidney disease and dyslipidemia are reviewed. Because of the lack of evidence in treating lipid abnormalities in this specific patient population, we propose that future studies should focus on the pathophysiological mechanisms and treatment of dyslipidemia in this special patient population.

Original languageEnglish (US)
Pages (from-to)165-177
Number of pages13
JournalCardioRenal Medicine
Volume3
Issue number3
DOIs
StatePublished - Oct 2013

Keywords

  • Chronic kidney disease
  • Dyslipidemia
  • End-stage renal disease
  • Oxidized low-density lipoprotein

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Urology

Fingerprint Dive into the research topics of 'Dyslipidemia in patients with chronic and end-stage kidney disease'. Together they form a unique fingerprint.

  • Cite this